Cytotoxic effects of four aescin types on human colon adenocarcinoma cell lines

Natural Product Communications

Volumn 9, Issue 3, 2014, Pages 387-390

  Seweryn, Ewa ^a   Gleńsk, Michał ^a   Środa Pomianek, Kamila ^a   Ceremuga, Ireneusz ^a   Włodarczyk, Maciej ^a   Gamian, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Aescin (escin); Colon adenocarcinoma; Cytotoxicity; LoVo; LoVo Dx

Indexed keywords

BETA ESCIN; BETA ESCIN AMORPHOUS; BETA ESCIN CRYSTALLINE; BETA ESCIN SODIUM; DOXORUBICIN; ESCIN; ESCIN POLYSULFATE; SULFORHODAMINE B; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DOSE RESPONSE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; MTT ASSAY; SULFORHODAMINE B ASSAY;

ADENOCARCINOMA; AESCULUS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ESCIN; HUMANS;

EID: 84895451789     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1400900328     Document Type: Article

References (22)

1. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert, Fric BP. (2009) Colorectal cancer screening in Europe. World Journal of Gastroenterology, 15, 5907-5915.
2. Aggarwal B, Prasad S, Sung B, Krishnan S, Guha S. (2013) Prevention and treatment of colorectal cancer by natural agents from mother nature. Current Colorectal Cancer Reports, 9, 37-56
3. Sirtori CR. (2001) Aescin: Pharmacology, pharmacokinetic and therapeutic profile. Pharmacological Research, 44, 183-193.
4. Hostettmann KA, Marston A. (1995). Saponins. Chemistry and pharmacology of natural products. Cambridge University Press, Cambridge, UK.
5. Tan SM, Li F, Rajendran P, Kumar AP, Hui KM, Sethi G. (2010) Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. Journal of Pharmacology and Experimental Therapeutics, 334, 285-293.
6. Güney G, Kutlu HM, Iscan A. (2012) The apoptotic effects of escin in the H-Ras transformed 5RP7 cell line. Phytotherapy Research, DOI: 10.1002/ptr.4804.
7. Zhang Z, Gao J, Cai X, Zhao Y, Wang Y, Lu W, Gu Z, Zhang S, Cao P. (2011) Escin sodium induces apoptosis of human acute leukemia Jurkat T cells. Phytotherapy Research, 25, 1747-1755.
8. Fechir M, Linker K, Pautz A, Hubrich T, Förstermann U, Rodriguez-Pascual F, Kleinert H. (2005) Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Molecular Pharmacology, 67, 2148-2161.
9. Ji DB, Xu B, Liu JT, Ran FX, Cui JR. (2011) B-Escin sodium inhibits inducible nitric oxide synthase expression via downregulation of the JAK/STAT pathway in A549 cells. Molecular Carcinogenesis, 50, 945-960.
10. Jiang N, Xin W, Wang T, Zhang L, Fan H, Du Y, Li C, Fu F. (2011) Protective effect of aescin from the seeds of Aesculus hippocastanum on liver injury induced by endotoxin in mice. Phytomedicine, 18, 1276-1284.
11. Frick RW. (2000) Three treatments for chronic venous insuffiency: escin, hydroxyethylrutoside and Daflon. Angiology, 51, 197-205.
12. Harikumar KB, Sung B, Pandey MK, Guha S, Krishnan S, Aggarwal BB. (2010) Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-κB signaling pathway. Molecular Pharmacology, 77, 818-827.
13. Pharmeuropa (2008) 20, 3. 477-480
14. Molinari A, Calcabrini A, Meschini S, Stringaro A, Crateri P, Toccacieli L, Marra M, Colone M, Cianfriglia M, Arancia G. (2002) Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells. Current Protein and Peptide Science 3, 653-670.
15. Podolak I, Galanty A, Sobolewska D. (2010) Saponins as cytotoxic agents: a review. Phytochemistry Reviews, 9, 425-474.
16. Man S, Gao W, Zhang Y, Huang L, Liu C. (2010) Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia, 81, 703-714.
17. Herrmann F, Wink M. (2011) Synergistic interactions of saponins and monoterpenes in HeLa cells, Cos7 cells and in erythrocytes. Phytomedicine, 18, 1191-1196.
18. Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B. (2012) Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo. Journal of Cancer Research and Clinical Oncology, 138, 785-797.
19. Du Y, Wang T, Jiang N, Ren RT, Li C, Li CK, Fu FH. (2012) Sodium aescinate ameliorates liver injury induced by methyl parathion in rats. Experimental and Therapeutic Medicine, 3, 818-822.
20. Xin W, Zhang L, Fan H, Jiang N, Wang T, Fu F. (2011) Escin attenuates acute lung injury induced by endotoxin in mice. European Journal of Pharmaceutical Sciences, 42, 73-80.
21. Kim SW, Kwon H, Chi DW, Shim JH, Park JD, Lee YH, Pyo S, Rhee DK. (2003) Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3. Biochemical Pharmacology, 65, 75-82.
22. Vanicha V, Kanyawim K. (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature, 1, 1112-1116.